INDEPENDENT THINKING. WHOLE-FOOD LIVING.NO ANIMALS / NO OIL
THENANODIET
← THE EVIDENCE INDEX

The Study Library.

8,456 peer-reviewed studies, each with a short note written from its published abstract: what kind of study it was, who took part, what was measured and what the authors reported. Observational studies show associations, not proof.

Showing studies that examined mushrooms. Clear

People assigned to a diet, food or program and measured.

4 studies

2020 / Pilot double-blind randomized placebo-controlled trial

Erinacine A-enriched Hericium erinaceus mycelia capsules for 49 weeks improved cognitive scores and contrast sensitivity in patients with mild Alzheimer's disease.

Patients with mild Alzheimer's disease were randomized to receive three 350 mg erinacine A-enriched Hericium erinaceus mycelia (EAHE) capsules per day (5 mg/g erinacine A) or placebo for 49 weeks following a 3-week screening period. After 49 weeks, the EAHE group showed significant improvement in MMSE score, a significant difference in IADL score compared to placebo, and a significant decrease in CASI score was noted only in the placebo group. The EAHE group also achieved significantly better contrast sensitivity and showed differences in biomarkers and neuroimaging ADC values compared to placebo. Four subjects dropped out due to abdominal discomfort, nausea, and skin rash, with no other adverse events reported.

Li IC, Chang HH, Lin CH, et al. Front Aging Neurosci, 2020. PMID 32581767

2020 / Randomized, double-blinded, placebo-controlled clinical trial

Supplementation with vitamin D3 or vitamin D-enriched mushrooms showed no significant effect on cognitive function or mood in healthy older adults.

A 6-month trial examined the effects of vitamin D3, enhanced vitamin D2 in a mushroom matrix, standard mushroom, and placebo in 436 healthy adults aged ≥60 years. Total 25-OH-D and 25-OH-D3 levels were maintained in the vitamin D3 arm but decreased significantly (p < 0.05) in the other three arms. There were no significant effects of treatment on any measures of cognitive function or mood over 24 weeks.

Zajac IT, Barnes M, Cavuoto P, et al. Nutrients, 2020. PMID 33339304

2019 / Randomized, double-blind, placebo-controlled parallel-group comparative study

Oral intake of Hericium erinaceus supplements for 12 weeks significantly improved MMSE cognitive function scores.

A randomized, double-blind, placebo-controlled parallel-group comparative study evaluated the effect of Hericium erinaceus fruiting body supplements taken for 12 weeks on cognitive functions. Cognitive performance was assessed using the Mini Mental State Examination (MMSE), Benton visual retention test, and Standard verbal paired-associate learning test (S-PA). MMSE alone showed that oral intake of H. erinaceus significantly improved cognitive functions and prevented deterioration.

Saitsu Y, Nishide A, Kikushima K, et al. Biomed Res, 2019. PMID 31413233

2009 / Double-blind, parallel-group, placebo-controlled randomized trial

Yamabushitake (Hericium erinaceus) supplementation significantly improved cognitive function scores in adults with mild cognitive impairment.

Thirty Japanese men and women aged 50 to 80 with mild cognitive impairment were randomized to take either Yamabushitake (four 250 mg tablets containing 96% dry powder three times daily) or placebo for 16 weeks, followed by 4 weeks of observation. At weeks 8, 12, and 16, the Yamabushitake group showed significantly increased cognitive function scale scores compared with placebo, with scores increasing with duration of intake. However, scores decreased significantly by 4 weeks after terminating intake. Laboratory tests showed no adverse effects.

Mori K, Inatomi S, Ouchi K, et al. Phytother Res, 2009. PMID 18844328